70 related articles for article (PubMed ID: 20636329)
1. Effective and specific inhibition of the CD40-CD154 costimulatory interaction by a naphthalenesulphonic acid derivative.
Margolles-Clark E; Kenyon NS; Ricordi C; Buchwald P
Chem Biol Drug Des; 2010 Oct; 76(4):305-13. PubMed ID: 20636329
[TBL] [Abstract][Full Text] [Related]
2. Organic dyes as small molecule protein-protein interaction inhibitors for the CD40-CD154 costimulatory interaction.
Buchwald P; Margolles-Clark E; Kenyon NS; Ricordi C
J Mol Recognit; 2010; 23(1):65-73. PubMed ID: 19621420
[TBL] [Abstract][Full Text] [Related]
3. Small-molecule costimulatory blockade: organic dye inhibitors of the CD40-CD154 interaction.
Margolles-Clark E; Umland O; Kenyon NS; Ricordi C; Buchwald P
J Mol Med (Berl); 2009 Nov; 87(11):1133-43. PubMed ID: 19707732
[TBL] [Abstract][Full Text] [Related]
4. The food colorant erythrosine is a promiscuous protein-protein interaction inhibitor.
Ganesan L; Margolles-Clark E; Song Y; Buchwald P
Biochem Pharmacol; 2011 Mar; 81(6):810-8. PubMed ID: 21219880
[TBL] [Abstract][Full Text] [Related]
5. Exploratory computational assessment of possible binding modes for small molecule inhibitors of the CD40-CD154 co-stimulatory interaction.
Ganesan L; Vidović D; Schürer SC; Buchwald P
Pharmazie; 2012 May; 67(5):374-9. PubMed ID: 22764566
[TBL] [Abstract][Full Text] [Related]
6. Prospects for CD40-directed experimental therapy of human cancer.
Tong AW; Stone MJ
Cancer Gene Ther; 2003 Jan; 10(1):1-13. PubMed ID: 12489023
[TBL] [Abstract][Full Text] [Related]
7. Complete rejection of a T-cell lymphoma due to synergism of T-cell receptor costimulatory molecules, CD80, CD40L, and CD40.
Ruybal P; Gravisaco MJ; Barcala V; Escalada A; Di Sciullo P; Waldner C; Mongini C
Vaccine; 2008 Jan; 26(5):697-705. PubMed ID: 18155328
[TBL] [Abstract][Full Text] [Related]
8. CD154-CD40 interactions are essential for thymus-dependent antibody production in zebrafish: insights into the origin of costimulatory pathway in helper T cell-regulated adaptive immunity in early vertebrates.
Gong YF; Xiang LX; Shao JZ
J Immunol; 2009 Jun; 182(12):7749-62. PubMed ID: 19494299
[TBL] [Abstract][Full Text] [Related]
9. CD154/CD40-mediated expression of CD154 in endothelial cells: consequences for endothelial cell-monocyte interaction.
Wagner AH; Güldenzoph B; Lienenlüke B; Hecker M
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):715-20. PubMed ID: 14976003
[TBL] [Abstract][Full Text] [Related]
10. Small-Molecule Inhibitors of the CD40-CD40L Costimulatory Protein-Protein Interaction.
Chen J; Song Y; Bojadzic D; Tamayo-Garcia A; Landin AM; Blomberg BB; Buchwald P
J Med Chem; 2017 Nov; 60(21):8906-8922. PubMed ID: 29024591
[TBL] [Abstract][Full Text] [Related]
11. Disruption of CD154:CD40 blocks generation of allograft immunity without affecting APC activation.
Shepherd DM; Kerkvliet NI
J Immunol; 1999 Sep; 163(5):2470-7. PubMed ID: 10452982
[TBL] [Abstract][Full Text] [Related]
12. Expression of tumour necrosis factor (TNF) receptor/ligand superfamily co-stimulatory molecules CD40, CD30L, CD27L, and OX40L in murine hearts with chronic ongoing myocarditis caused by coxsackie virus B3.
Seko Y; Takahashi N; Oshima H; Shimozato O; Akiba H; Kobata T; Yagita H; Okumura K; Azuma M; Yazaki Y
J Pathol; 1999 Aug; 188(4):423-30. PubMed ID: 10440754
[TBL] [Abstract][Full Text] [Related]
13. Suramin inhibits the CD40-CD154 costimulatory interaction: a possible mechanism for immunosuppressive effects.
Margolles-Clark E; Jacques-Silva MC; Ganesan L; Umland O; Kenyon NS; Ricordi C; Berggren PO; Buchwald P
Biochem Pharmacol; 2009 Apr; 77(7):1236-45. PubMed ID: 19283894
[TBL] [Abstract][Full Text] [Related]
14. A family of ligands for the TNF receptor superfamily.
Cosman D
Stem Cells; 1994 Sep; 12(5):440-55. PubMed ID: 7528588
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of antitumor activity of CD40L, RANKL, and 4-1BBL in vivo following intratumoral administration of viral vectors or transduced dendritic cells.
Yurkovetsky ZR; Shurin GV; Barry DA; Schuh AC; Shurin MR; Robbins PD
J Gene Med; 2006 Feb; 8(2):129-37. PubMed ID: 16288496
[TBL] [Abstract][Full Text] [Related]
16. Cooperativity in the interaction of synthetic CD40L mimetics with CD40 and its implication in cell signaling.
Wieckowski S; Trouche N; Chaloin O; Guichard G; Fournel S; Hoebeke J
Biochemistry; 2007 Mar; 46(11):3482-93. PubMed ID: 17319699
[TBL] [Abstract][Full Text] [Related]
17. CD40/CD40L interaction induces Abeta production and increases gamma-secretase activity independently of tumor necrosis factor receptor associated factor (TRAF) signaling.
Volmar CH; Ait-Ghezala G; Frieling J; Weeks OI; Mullan MJ
Exp Cell Res; 2009 Aug; 315(13):2265-74. PubMed ID: 19422822
[TBL] [Abstract][Full Text] [Related]
18. Costimulatory molecule CD154 in systemic lupus erythematosus and rheumatoid arthritis. Therapeutic perspectives.
Dejica DI; Manea EM
Roum Arch Microbiol Immunol; 2006; 65(1-2):66-74. PubMed ID: 17877113
[TBL] [Abstract][Full Text] [Related]
19. Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses.
Taraban VY; Rowley TF; O'Brien L; Chan HT; Haswell LE; Green MH; Tutt AL; Glennie MJ; Al-Shamkhani A
Eur J Immunol; 2002 Dec; 32(12):3617-27. PubMed ID: 12516549
[TBL] [Abstract][Full Text] [Related]
20. Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production.
Liu Z; Colpaert S; D'Haens GR; Kasran A; de Boer M; Rutgeerts P; Geboes K; Ceuppens JL
J Immunol; 1999 Oct; 163(7):4049-57. PubMed ID: 10491009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
